Clinical Trials
6 trialsNCT07584057 2026-05-13
An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia
Yunnan Baiyao Group Co., Ltd.
Phase 1/2 Not yet recruiting
NCT06476197 2025-07-17
Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy
S-Alpha Therapeutics, Inc.
Phase NA Completed
NCT05264038 2023-03-20
A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514
Oncocross Co. Ltd.
Phase 1 Completed
NCT02359123 2018-04-10
Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients
Cannabics Pharmaceuticals Inc.
Phase NA Completed
NCT00267358 2013-09-02
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
Helsinn Therapeutics (U.S.), Inc
Phase 2 Completed
NCT00378131 2013-09-02
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
Helsinn Therapeutics (U.S.), Inc
Phase 2 Completed